LitCovid-sentences  

PMC:7417114 / 1520-2759 JSONTXT 8 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T10 0-146 Sentence denotes A novel human coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly named 2019-nCoV), emerged in Wuhan, China.
T11 147-330 Sentence denotes The outbreak in the previously unexposed human population was marked by high morbidity caused by SARS-CoV-2 as a result of the associated disease COVID-19 (Corona Virus Disease-2019).
T12 331-486 Sentence denotes There is an urgent need for the development of therapies targeting both direct viral infection and the inflammatory immune response elicited by SARS-CoV-2.
T13 487-630 Sentence denotes While many patients with documented SARS-CoV-2 infections have mild symptomatology, pathology can be severe in a subset of patients (Figure 1).
T14 631-783 Sentence denotes Overall, COVID-19 has milder clinical manifestations and lower fatality than infections by the related viruses, SARS-CoV and MERS-CoV (Figures 1 and 2).
T15 784-825 Sentence denotes However, COVID-19 infection can be fatal.
T16 826-1150 Sentence denotes Repurposing of drugs that have pre-existing FDA-approval as treatments for SARS-CoV-2 and related coronaviruses offers an attractive opportunity for the rapid deployment of effective therapeutics in the setting of the current pandemic outbreak, where treatment options are largely limited to supportive and symptomatic care.
T17 1151-1160 Sentence denotes Figure 1.
T18 1161-1179 Sentence denotes Covid-19 symptoms.
T19 1180-1189 Sentence denotes Figure 2.
T20 1190-1239 Sentence denotes Comparison of MERS-CoV, SARS-CoV, and SARS-CoV-2.